Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.
CAS Number : 619331-35-0
End Use API : Fostemsavir
About The Company : Founded in 2006, ChemExpress specializes in offering CRO & CDMO services for pharmaceutical and biotech companies, focusing on small molecules, biologics and ne...
ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.
CAS Number : 446284-32-8
End Use API : Fostemsavir
About The Company : Founded in 2006, ChemExpress specializes in offering CRO & CDMO services for pharmaceutical and biotech companies, focusing on small molecules, biologics and ne...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Annual Reports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]US Patents
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
53
PharmaCompass offers a list of Fostemsavir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fostemsavir manufacturer or Fostemsavir supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fostemsavir manufacturer or Fostemsavir supplier.
PharmaCompass also assists you with knowing the Fostemsavir API Price utilized in the formulation of products. Fostemsavir API Price is not always fixed or binding as the Fostemsavir Price is obtained through a variety of data sources. The Fostemsavir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fostemsavir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fostemsavir, including repackagers and relabelers. The FDA regulates Fostemsavir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fostemsavir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fostemsavir supplier is an individual or a company that provides Fostemsavir active pharmaceutical ingredient (API) or Fostemsavir finished formulations upon request. The Fostemsavir suppliers may include Fostemsavir API manufacturers, exporters, distributors and traders.
click here to find a list of Fostemsavir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fostemsavir as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fostemsavir API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fostemsavir as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fostemsavir and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fostemsavir NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fostemsavir suppliers with NDC on PharmaCompass.
Fostemsavir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fostemsavir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fostemsavir GMP manufacturer or Fostemsavir GMP API supplier for your needs.
A Fostemsavir CoA (Certificate of Analysis) is a formal document that attests to Fostemsavir's compliance with Fostemsavir specifications and serves as a tool for batch-level quality control.
Fostemsavir CoA mostly includes findings from lab analyses of a specific batch. For each Fostemsavir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fostemsavir may be tested according to a variety of international standards, such as European Pharmacopoeia (Fostemsavir EP), Fostemsavir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fostemsavir USP).
